Last checked at 25 May 2023 12:26
25 May 2023
Polar Capital Holdings plc
Issue of Equity
Polar Capital Holdings plc ("Polar Capital" or the "Company") announces that today 405,154 ordinary shares of 2.5 pence in the Company have been allotted and issued, each fully paid, under its block listing facility (Crystallisation of Preference Shares) in respect of the previously announced partial crystallisation of the Global Convertible Bond Fund, and the crystallisation of the Biotechnology Fund (both in RNS Number 0101S on 11 November 2021). These shares will rank pari passu in all respects with the Company's existing shares in issue.
This issue comprises the third allotment in respect of the Global Convertible Fund and the Biotechnology Fund, for a total of 405,154 ordinary shares.
The Company's current issued share capital is 100,790,725 ordinary shares and following this allotment, the total number of ordinary shares allotted and in issue will be 101,195,879.
Background
As set out at the time of the Company's admission to AIM, Polar Capital has structured its fund management operations in such a way that the fund management teams are placed in separate business units. Each business unit is a separate profit centre and the fund managers responsible receive an annual payment which comprises a share of their unit's core operating profit (operating profit before performance fees and related distributions) and performance fees.
In addition, each fund management team is offered the prospect of an interest in the capital of the Company through the purchase of an individual class of preference shares in Polar Capital Partners Limited, a wholly owned subsidiary of the Company. These preference shares have been structured in such a way as to become convertible upon the occurrence of certain events known as crystallisation events into cash or, at the option of the Company, ordinary shares in the Company at a ratio that is intended to be earnings enhancing for the Group.
Upon the occurrence of a crystallisation event the fund managers concerned cease to be eligible to receive their share of the business unit's core operating profit and simultaneously going forward receive a reduced interest in their performance fees.
For further information please contact:
Polar Capital +44 (0)20 7227 2700
Gavin Rochussen (Chief Executive)
Samir Ayub (Finance Director)
Numis Securities Limited - Nomad and Joint Broker +44 (0)20 7260 1000
Giles Rolls (QE)
Charles Farquhar
Stephen Westgate
Peel Hunt LLP - Joint Broker +44 (0)20 3597 8680
Andrew Buchanan
Camarco +44 (0)20 7757 4995
Ed Gascoigne-Pees
Jennifer Renwick
Phoebe Pugh